180 Life Sciences Corp. announced a change in its Board of Directors with the resignation of Jay Goodman, effective June 13, 2025. The company confirmed that Goodman's departure was not due to any disagreements related to company operations or policies. Additionally, the Board adopted the 2025 Option Incentive Plan, pending shareholder approval.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 180 Life Sciences Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-055701), on June 18, 2025, and is solely responsible for the information contained therein.